| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/01/2001 | CA2376465A1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 02/01/2001 | CA2375571A1 Human nervous system-associated proteins |
| 01/31/2001 | EP1072601A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072596A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072595A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072594A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072592A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1071781A1 B-cell growth factor related protein |
| 01/31/2001 | EP1071718A1 Matrix binding factor |
| 01/31/2001 | EP1071704A1 Novel matrix metalloproteinase inhibitors and down-regulators |
| 01/31/2001 | EP1071686A1 Novel heterocyclic compounds |
| 01/31/2001 | EP1071680A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 01/31/2001 | EP1071679A1 Novel heterocyclic compounds |
| 01/31/2001 | EP1071472A1 Peptides for efficient gene transfer |
| 01/31/2001 | EP1071463A1 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 01/31/2001 | EP1071462A1 Methods and compositions using norastemizole in combination with leukotriene inhibitors |
| 01/31/2001 | EP1071450A2 Combination of antigen pulsed apcs and interleukin 12 for tumour and viral therapy |
| 01/31/2001 | EP1071448A1 Use of protease inhibitors for treating skin wounds |
| 01/31/2001 | EP1071445A2 Therapeutic angiogenic factors and methods for their use |
| 01/31/2001 | EP1071440A1 Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
| 01/31/2001 | EP1071433A2 Pharmaceutical composition |
| 01/31/2001 | EP1071431A1 Novel delivery of hydroxy carboxylic acids |
| 01/31/2001 | EP1071417A1 Use of cannabinoids as anti-inflammatory agents |
| 01/31/2001 | EP0768884B1 Drugs containing a synergistic mixture of metronidazole and clindamycin |
| 01/31/2001 | CN1282372A Mammalian sytokine-like polypeptide-10 |
| 01/31/2001 | CN1282254A Compositions and methods for regulating phagocytosis and ICAM-1 expression |
| 01/31/2001 | CN1281711A Shaoshang Shengpi powder for curing burn and its preparation method |
| 01/31/2001 | CN1281697A Multifunctional medicine |
| 01/31/2001 | CN1061258C Chinese medicine powder for curing ringworm of foot, and preparing method |
| 01/31/2001 | CN1061248C Powder agent formula for curing acne and seborrhea and production method |
| 01/31/2001 | CN1061236C Ointment for curing eczema |
| 01/30/2001 | US6181962 Electrically activated substance and method for making the same |
| 01/30/2001 | US6180674 Therapy for skin disorders |
| 01/30/2001 | US6180669 Method for treatment of dermatological disorders |
| 01/30/2001 | US6180662 Mixture of cinnamic acid, antioxidant, enzyme, microbiocides and viricides |
| 01/30/2001 | US6180650 Antiinflammatory agents; respiratory system disorders; skin disorders; antitumor agents |
| 01/30/2001 | US6180643 Antagonist of interleukins, tumor necrosis factor |
| 01/30/2001 | US6180635 Novel thieno(2,3-d)pyrimidinediones which exhibit pharmacological activity, in particular immunosuppressive activity; treating allograft rejection |
| 01/30/2001 | US6180632 Use of these compounds for treating disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or t cell activation and proliferation |
| 01/30/2001 | US6180623 Used as analgesics and anti-pruritic agents |
| 01/30/2001 | US6180601 Freeze-dried soft, flexible and continous matrix of hyaluronic acid containing peptide or protein used for wound healing |
| 01/30/2001 | US6180403 Antisense inhibition of tumor necrosis factor alpha converting enzyme (TACE) expression |
| 01/30/2001 | US6180387 Nucleotide sequence coding an enzymatic polypeptide; for the detection of bactericides and batericidal agonist and antagonists which prevent bacterial infection |
| 01/30/2001 | US6180116 Histidine derivatives, preparation process and uses |
| 01/30/2001 | US6179883 2-imino-2,3-dihydro-1H-indole derivatives for dyeing keratin fibers |
| 01/30/2001 | CA2191352C Quinoline derivatives as tachykinin nk3 receptor antagonists |
| 01/30/2001 | CA2148112C New pharmaeutical dosage form for transdermal administration |
| 01/27/2001 | CA2314569A1 Methods for treating skin pigmentation |
| 01/25/2001 | WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 01/25/2001 | WO2001005974A2 The il-1l1 gene and polypeptide products |
| 01/25/2001 | WO2001005972A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | WO2001005942A2 Improved keratinocyte culture and uses thereof |
| 01/25/2001 | WO2001005834A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | WO2001005823A2 Tryptase inhibitor |
| 01/25/2001 | WO2001005816A1 Amine-modified pseudomycin compounds |
| 01/25/2001 | WO2001005813A1 Pseudomycin prodrugs |
| 01/25/2001 | WO2001005810A2 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN αVβ¿6? |
| 01/25/2001 | WO2001005790A1 New compounds |
| 01/25/2001 | WO2001005783A1 Bradykinin b1 receptor antagonists |
| 01/25/2001 | WO2001005776A1 Aminothiazole derivatives and their use as crf receptor ligands |
| 01/25/2001 | WO2001005772A1 Pyrazinones, compositions containing such compounds |
| 01/25/2001 | WO2001005770A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
| 01/25/2001 | WO2001005751A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005749A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005746A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005745A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005744A1 Novel aminobenzophenones |
| 01/25/2001 | WO2001005445A2 A carbon dioxide generating device for medical treatment |
| 01/25/2001 | WO2001005443A1 Adhesive protein foam for surgical and/or therapeutic uses |
| 01/25/2001 | WO2001005422A2 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 01/25/2001 | WO2001005406A1 Glycyrrhizin preparations for transmucosal absorption |
| 01/25/2001 | WO2001005400A1 Nitroimidazole external preparations for dermatosis |
| 01/25/2001 | WO2001005397A1 Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having effective composition of the same |
| 01/25/2001 | WO2001005392A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | WO2001005390A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | WO2001005368A1 Use of at least one extract of a plant of the genus lannea in a cosmetic or dermopharmaceutical composition |
| 01/25/2001 | WO2001005364A1 Nitrogen-containing steroid compounds and their use to regulate hair growth |
| 01/25/2001 | WO2001005362A2 Emulsifier-free finely dispersed water-in-oil-type systems |
| 01/25/2001 | WO2001005357A1 Two-component composition for cosmetic or pharmaceutical use |
| 01/25/2001 | WO2000066587A3 Polyamines and their use in therapy |
| 01/25/2001 | WO2000066111B1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions |
| 01/25/2001 | WO2000061171A3 Uses of mammalian ox2 protein and related reagents |
| 01/25/2001 | WO2000060080A3 Molecules of the immune system |
| 01/25/2001 | WO2000059940A3 Platelet-derived growth factor related gene and protein |
| 01/25/2001 | WO2000058473A3 Nucleic acids including open reading frames encoding polypeptides; 'orfx' |
| 01/25/2001 | WO2000044740A3 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 01/25/2001 | DE19934585A1 Treatment of dermatological disorders, e.g. pruritus, herpes simplex infection, psoriasis or acne, using tosyl chloramide salt, e.g. in ointment or gel base |
| 01/25/2001 | CA2381327A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | CA2379627A1 Inhibitor proteins |
| 01/25/2001 | CA2379554A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
| 01/25/2001 | CA2379489A1 Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having effective composition of the same |
| 01/25/2001 | CA2379336A1 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 01/25/2001 | CA2379319A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379317A1 Amine-modified pseudomycin compounds |
| 01/25/2001 | CA2379316A1 Novel aminobenzophenones |
| 01/25/2001 | CA2379313A1 Glycyrrhizin preparations for transmucosal absorption |
| 01/25/2001 | CA2379293A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379286A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379273A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379064A1 Bradykinin b1 receptor antagonists |